These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 1688278)
1. [Overcoming the multiple drug resistance of tumors]. Donenko FV; Sitdikova SM; Moroz LV Vopr Onkol; 1991; 37(11-12):1034-41. PubMed ID: 1688278 [No Abstract] [Full Text] [Related]
2. [Overcoming resistance in tumors]. Volm M; Efferth T Dtsch Med Wochenschr; 1994 Mar; 119(13):475-9. PubMed ID: 7908869 [No Abstract] [Full Text] [Related]
3. [Calcium antagonist as biological modulator in cancer chemotherapy]. Tsuruo T Nihon Rinsho; 1989 Aug; 47(8):1851-6. PubMed ID: 2573744 [No Abstract] [Full Text] [Related]
4. [Multiple drug resistance. Biological and clinica implications]. Casals D; Cordón-Cardó C Med Clin (Barc); 1989 Jul; 93(5):181-5. PubMed ID: 2571755 [No Abstract] [Full Text] [Related]
5. Multiple drug resistance in cancer therapy. Schneider E; Cowan KH Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772 [No Abstract] [Full Text] [Related]
6. Resistance to natural products in leukemia. Borst P; Baas F; Lincke CR; Schinkel AH; Smit JJ; Van der Velde-Koerts T Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():44-7. PubMed ID: 1975205 [No Abstract] [Full Text] [Related]
7. [Glycoprotein in multidrug-resistant malignancies--clinical implications]. Ellis A; Lishner M; Manor J; Ravid M Harefuah; 1994 Mar; 126(6):334-7. PubMed ID: 7910806 [No Abstract] [Full Text] [Related]
8. Clinical relevance of P-glycoprotein with respect to the application of resistance modifiers. Scheulen ME Int J Clin Pharmacol Ther; 1998 Jan; 36(1):41-5. PubMed ID: 9476147 [No Abstract] [Full Text] [Related]
9. [Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential]. Larsson R; Nygren P; Bergh J Lakartidningen; 1991 Dec; 88(51-52):4441-4. PubMed ID: 1774991 [No Abstract] [Full Text] [Related]
10. [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field]. González-Manzano R Med Clin (Barc); 1994 Apr; 102(13):506-15. PubMed ID: 7911549 [No Abstract] [Full Text] [Related]
11. Multidrug resistance: focus in hematology. Carulli G; Petrini M Haematologica; 1990; 75(4):363-74. PubMed ID: 1980479 [TBL] [Abstract][Full Text] [Related]